Company page
Sagimet Biosciences Inc. - Series A
Sagimet Biosciences Inc. is a public company trading under the ticker SGMT in the American market. The company has a market capitalization of approximately $432.57 million. Sagimet focuses on developing innovative therapies, contributing to advancements in the biotechnology sector.
- Ticker
- SGMT:NASDAQ
- Asset type
- Stock
- Market cap
- $631.3M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD